Okazaki N, Yoshino M, Yoshida T, Takayasu K, Moriyama N, Makuuchi M, Yamazaki S, Hasegawa H, Noguchi M, Hirohashi S
Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
Hepatogastroenterology. 1990 Oct;37(5):480-3.
We describe the results of our study on the early detection of the development of hepatocellular carcinoma among patients with chronic liver disease. Over a period of 18 years, 33 patients were diagnosed as having hepatocellular carcinoma. From 1970 to 1978, we used serum alpha-fetoprotein determination, liver palpation, and radionuclide liver scans. In addition to alpha-fetoprotein determination, computed tomography and ultrasonography were introduced in 1979. However, we did not have any general guidelines for the use of these imaging modalities. From 1984 onwards, ultrasonography and serum alpha-fetoprotein determination have been performed every three months and computed tomography every year in patients whose right hepatic lobe had atrophied due to liver cirrhosis. On the basis of this screening program, 50% of the detected hepatocellular carcinoma (9/18) were found to be smaller than 1.9 cm in diameter, and tumor resection was performed in 11 out of 18 patients (61%).
我们描述了关于慢性肝病患者肝细胞癌发生早期检测的研究结果。在18年的时间里,33例患者被诊断为肝细胞癌。1970年至1978年期间,我们采用血清甲胎蛋白测定、肝脏触诊和放射性核素肝脏扫描。1979年除了甲胎蛋白测定外,还引入了计算机断层扫描和超声检查。然而,我们对于这些成像方式的使用没有任何通用指南。从1984年起,对于因肝硬化导致右肝叶萎缩的患者,每三个月进行一次超声检查和血清甲胎蛋白测定,每年进行一次计算机断层扫描。基于这一筛查方案,所检测出的肝细胞癌中有50%(9/18)直径小于1.9厘米,18例患者中有11例(61%)进行了肿瘤切除。